Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Relationship between plasma fibrinogen levels and pulmonary function in the japanese population: the Takahata study.

Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Kishi H, Nunomiya K, Nakano H, Sato M, Sato K, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I.

Int J Med Sci. 2013 Sep 1;10(11):1530-6. doi: 10.7150/ijms.7256. eCollection 2013.

2.

Association between plasma adiponectin levels and decline in forced expiratory volume in 1 s in a general Japanese population: the Takahata study.

Sato K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Nunomiya K, Nakano H, Sato M, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I.

Int J Med Sci. 2014 May 21;11(8):758-64. doi: 10.7150/ijms.8919. eCollection 2014.

3.

Hyperhomocysteinaemia predicts the decline in pulmonary function in healthy male smokers.

Nunomiya K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Kishi H, Sato M, Watanabe T, Konta T, Ueno Y, Kato T, Yamashita H, Kayama T, Kubota I.

Eur Respir J. 2013 Jul;42(1):18-27. doi: 10.1183/09031936.00066212. Epub 2012 Nov 8.

4.

The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study.

Aida Y, Shibata Y, Osaka D, Abe S, Inoue S, Fukuzaki K, Tokairin Y, Igarashi A, Yamauchi K, Nemoto T, Nunomiya K, Kishi H, Sato M, Watanabe T, Konta T, Kawata S, Kato T, Kubota I.

Int J Med Sci. 2011;8(6):470-8. Epub 2011 Aug 5.

5.
6.

FEV6 and FEV1/FEV6 in Japanese participants of the community-based annual health check: the Takahata study.

Kishi H, Shibata Y, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Sato M, Aida Y, Watanabe T, Konta T, Kawata S, Kato T, Kubota I.

Intern Med. 2011;50(2):87-93. Epub 2011 Jan 15.

7.

Elevated serum iron is a potent biomarker for spirometric resistance to cigarette smoke among Japanese males: the Takahata study.

Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Aida Y, Nunomiya K, Sato M, Nakano H, Sato K, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I.

PLoS One. 2013 Sep 9;8(9):e74020. doi: 10.1371/journal.pone.0074020. eCollection 2013.

8.

People with older age and lower FEV1%pred tend to have a smaller FVC than VC in pre-bronchodilator spirometry.

Wang W, Ma D, Li T, Ying Y, Xiao W.

Respir Physiol Neurobiol. 2014 Apr 1;194:1-5. doi: 10.1016/j.resp.2014.01.003. Epub 2014 Jan 18.

PMID:
24448311
9.

Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study.

Morseth B, Melbye H, Waterloo S, Thomassen MR, Risberg MJ, Emaus N.

BMC Geriatr. 2013 Oct 29;13:116. doi: 10.1186/1471-2318-13-116.

10.

Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) variability in asymptomatic never-smoking men.

Humerfelt S, Eide GE, Kvåle G, Gulsvik A.

Clin Physiol. 1998 Jul;18(4):387-96.

PMID:
9715766
11.

Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.

Chambers DC, Boldy DA, Ayres JG.

Respir Med. 1999 Oct;93(10):726-33.

PMID:
10581662
12.

Body composition and pulmonary function in the elderly: a 7-year longitudinal study.

Rossi A, Fantin F, Di Francesco V, Guariento S, Giuliano K, Fontana G, Micciolo R, Solerte SB, Bosello O, Zamboni M.

Int J Obes (Lond). 2008 Sep;32(9):1423-30. doi: 10.1038/ijo.2008.103. Epub 2008 Jul 22.

PMID:
18645577
13.

Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.

Allen S, Yeung P, Janczewski M, Siddique N.

Clin Respir J. 2008 Oct;2(4):208-13. doi: 10.1111/j.1752-699X.2008.00063.x.

PMID:
20298336
14.

Post-bronchodilator spirometry reference values in adults and implications for disease management.

Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A.

Am J Respir Crit Care Med. 2006 Jun 15;173(12):1316-25. Epub 2006 Mar 23.

PMID:
16556696
15.

Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.

Lindberg A, Larsson LG, Rönmark E, Jonsson AC, Larsson K, Lundbäck B.

COPD. 2007 Mar;4(1):5-13.

PMID:
17364672
16.

Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.

Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A, Powell JT, Lowe GD.

J Vasc Surg. 2006 Mar;43(3):474-80.

17.

Spirometric reference values for an East-African population.

Musafiri S, van Meerbeeck JP, Musango L, Derom E, Brusselle G, Joos G, Rutayisire C.

Respiration. 2013;85(4):297-304. doi: 10.1159/000337256. Epub 2012 May 11.

18.

Spirometric and anthropometric determinants of forced expiratory time in a general population.

Kainu A, Lindqvist A, Sarna S, Sovijärvi A.

Clin Physiol Funct Imaging. 2008 Jan;28(1):38-42. doi: 10.1111/j.1475-097X.2007.00771.x.

PMID:
18171402
19.

Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.

Lundgren FL, Cabral MM, Clímaco DC, de Macedo LG, Coelho Mde A, Dias AL.

J Bras Pneumol. 2007 Mar-Apr;33(2):148-51. English, Portuguese.

20.

New reference values for forced spirometry in white adults in Brazil.

Pereira CA, Sato T, Rodrigues SC.

J Bras Pneumol. 2007 Jul-Aug;33(4):397-406. English, Portuguese.

Supplemental Content

Support Center